Holen Sie sich die Stockscreener-App
273.33
3.05%
-8.60
Handel nachbörslich:
274.00
0.67
+0.25%
Schlusskurs vom Vortag:
$281.93
Offen:
$283.1
24-Stunden-Volumen:
1.08M
Relative Volume:
0.62
Marktkapitalisierung:
$44.25B
Einnahmen:
$3.32B
Nettoeinkommen (Verlust:
$941.65M
KGV:
48.67
EPS:
5.6161
Netto-Cashflow:
$1.64B
1W Leistung:
-2.62%
1M Leistung:
-2.63%
6M Leistung:
+57.10%
1J Leistung:
-9.13%
1-Tages-Spanne:
$272.83
$284.59
1-Wochen-Bereich:
$272.54
$291.40
52-Wochen-Spanne:
$148.05
$310.50
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, TXG, BTSG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
273.33 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
76.63 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
93.50 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
60.25 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
97.67 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-02-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2026-01-13 | Fortgesetzt | Goldman | Sell |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-12 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-07 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-29 | Bestätigt | Needham | Buy |
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
AI Will Revolutionize Medicine. This Company Provides the Plumbing. - Barron's
Veeva Systems (VEEV) Advances AI Integration in Biopharma with A - GuruFocus
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Servier Partners with Veeva to Build Global Data Foundation - Intellectia AI
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Veeva Systems: Servier Adopts Veeva Opendata Globally to Scale Ai - marketscreener.com
A French drugmaker is building an AI-ready data foundation across more than 80 countries - Stock Titan
Servier Adopts Veeva OpenData Globally to Scale AI - marketscreener.com
Veeva Systems: Same Old Story, Same Rating Once Again - Seeking Alpha
Veeva Systems Inc. (NYSE:VEEV) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeat
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet - uk.finance.yahoo.com
Price to earnings forward of Veeva Systems Inc. Class A – LSE:0LO3 - TradingView
Is Veeva Systems Stock Underperforming the Dow? - inkl
Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade) - Seeking Alpha
Form 4 Veeva Systems Inc Class A For: 27 September By Investing.com - Investing.com Canada
Veeva says its new AI agent can build a clinical study in a day - RuntimeWire
Veeva Systems (NYSE:VEEV) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know - Yahoo Finance
What Is Behind Veeva (NYSE:VEEV) AI Study Builder Move? - Kalkine Media
Veeva Systems Inc (VEEV): GF Score of 100 Signals Strong Outperf - GuruFocus
Form 4 Veeva Systems Inc Class A For: 25 September - Investing.com India
Form 4 Veeva Systems Inc Class A For: 25 September By Investing.com - Investing.com Canada
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup - Zacks Investment Research
Veeva (VEEV) Down 2.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
If You Invested $100 In Veeva Systems Stock 10 Years Ago, You Would Have This Much Today - Benzinga
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients - Yahoo Finance
VEEV News | VEEVA SYSTEMS INC-CLASS A (NYSE:VEEV) - ChartMill
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks - Benzinga
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch - Yahoo Finance
Veeva SystemsVault CRM Extends Market Leadership as another Top 20 Biopharma Chooses Veeva - marketscreener.com
Veeva Launches Study Builder Agent to Accelerate Clinical Research - Intellectia AI
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day - Veeva
Veeva Systems (VEEV) Launches AI Study Builder Agent - TradingView
Can Veeva Systems (NYSE:VEEV) Hold Today’s Attention? - Kalkine Media
How Veeva Systems Inc. Class A (VEEV) Affects Rotational Strategy Timing - Stock Traders Daily
Is It Too Late to Buy Veeva Systems Inc (VEEV) After 3.8% Rally? GF Value Says Undervalued - GuruFocus
VEEV Stock Climbs As AI Vault CRM Momentum Fuels Target Hikes - StocksToTrade
Veeva Systems (NYSE:VEEV) Trading Up 2.8%What's Next? - MarketBeat
Effective Planning and Engagement for Patient Support Services - Veeva
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing - Your Wyoming Link
Veeva Systems gains new top 20 biopharma win for Vault CRM - Seeking Alpha
Why Veeva Systems (VEEV) Stock Is Up Today - Quiver Quantitative
Vault CRM Extends Market Leadership as Another Top 20 Biopharma Chooses Veeva - Veeva
Veeva Systems adds top 20 biopharma client for Vault CRM By Investing.com - Investing.com Canada
Veeva Systems (VEEV) Adds Another Top-20 Biopharma to Vault CRM - TradingView
Veeva Systems Inc. $VEEV Shares Sold by Andra AP fonden - MarketBeat
ETFs Are Net Sellers of Veeva Systems (VEEV) on Sept. 23 - gurufocus.com
What Is Veeva Systems (VEEV) Telling Investors With Its New Falcon Router? - simplywall.st
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar? - Zacks Investment Research
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):